OTC Cough, Cold & Allergy Medicine Market Highlighting Lucrative Avenues Across Major Geographies during 2017-2022

Posted on 2019-01-22 by Mark Hub in Healthcare, Industrial // 0 Comments

Rockville, USA, 2019-Jan-22 — /EPR Network/ — Fact.MR’s recently published report reveals that the OTC cough, cold and allergy medicine market is set to witness 4.9% between 2017 and 2022. This market is estimated to stand at around US$ 37,323 Mn towards the end of the forecast period.

A large number of people across the globe purchase OTC (over-the-counter) medicines for treating minor cough, cold or allergy related problems rather visiting the doctor. This has been a major reason behind the incessant sales of OTC cough, cold and allergy drugs

Key Players:

Key companies profiled in Fact.MR’s report include Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd.,

Request Sample Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=71

The OTC cough, cold and allergy medicine market is segmented as follows:

Drug Type
OTC Channel
Dosage

Browse Full Report on OTC cough, cold and allergy medicine market with TOC-

https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market

Global-OTC cough, cold and allergy medicine market report has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the market space. The report also includes Porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models.The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of industry professionals.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

On the basis of drug type, antihistamine is anticipated to command for over one-third revenues share of the market by the end of2017. Antihistamines drugs help in restricting the histamine release from histamine-1 receptors, moreover these drugs can effectively treat watery eyes or runny nose, inflammation (redness), sneezing and swelling (edema).

To Buy OTC cough, cold and allergy medicine market Report-

https://www.factmr.com/checkout/71/S

OTC cough, cold and allergy medicine market – Regional Overview & Competitive Backdrop A comprehensive section on the regional analysis of global OTC cough, cold and allergy medicine market is included in the report. North America, Europe, Japan, Asia-Pacific excluding Japan (APEJ), Latin America, and Middle East & Africa are key regions into which the expansion of global OTC cough, cold and allergy medicine market is studied.

Geographically, Asia-Pacific excluding Japan (APEJ) to Remain the Largest Market for OTC Cough, Cold and Allergy Medicines

The OTC cough, cold and allergy medicines market in Asia Pacific excluding Japan (APEJ) is anticipated to remain highly attractive throughout the assessment period. In 2017 and beyond, the region is projected to command for a noteworthy revenue share of the global market.

For More Information Send Enquiry:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=71

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick